Clinical trials
Completed Migraine Disorders trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 3 |
| 2010 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Teva Branded Pharmaceutical Products R&D, Inc. | 6 |
| Amgen | 5 |
| H. Lundbeck A/S | 4 |
| Pfizer | 3 |
| AbbVie | 2 |
| AstraZeneca | 1 |
| Endo USA Inc., a Keenova Therapeutics Company | 1 |
| Ipsen | 1 |
| Janssen Pharmaceutica N.V., Belgium | 1 |
| Swiat Zdrowia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Migraine Disorders | 26 |
| Headache | 9 |
| COVID-19 | 1 |
| Headache Disorders | 1 |
| Headache Disorders, Secondary | 1 |
| Major Depressive Disorder | 1 |
| Pain | 1 |
| Recurrence | 1 |
| Rhinosinusitis | 1 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.